17 employees
UPPTHERA is a pharmaceutical company that specializes in drug development using targeted protein degradation technology.
2018
$22M
from 5 investors over 5 rounds
UPPTHERA raised $22M on May 19, 2022
Investors: IBKC, IMM Investment Corp. and Paratus Investment Inc.
UPPTHERA raised undisclosed on July 22, 2020
Investors: KDB Capital Corp. and IMM Investment Corp.